Siebert Financial Corp. Announces the Launch of ‘Siebert.Valor’ in Honor of Service Members’ Financial Empowerment
NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) — Siebert Financial Corp. (NASDAQ: SIEB), a pioneer in the financial services industry, […]
CompoSecure Earns Global Recognition in 2024 with 9 Awards and 11 Finalist Honors
SOMERSET, N.J., Dec. 18, 2024 (GLOBE NEWSWIRE) — CompoSecure, Inc. (Nasdaq: CMPO), a leader in metal payment cards, security, and […]
Alliance Entertainment Acquires Handmade by Robots
PLANTATION, Fla., Dec. 18, 2024 (GLOBE NEWSWIRE) — Alliance Entertainment Holding Corporation (Nasdaq: AENT), a global distributor and wholesaler specializing […]
Rezolve Ai Announces $49 Million Equity Conversion by Leading Investors
NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV), a global leader in AI-driven retail innovation, and […]
Coherus to Present Final Phase 2 Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025
– Randomized Phase 2 study initiated evaluating the combination of casdozokitug, toripalimab and bevacizumab in patients with liver cancer – […]
Saratoga Investment Corp. to Report Fiscal Third Quarter 2025 Financial Results and Hold Conference Call
NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) — Saratoga Investment Corp. (NYSE:SAR), a business development company, will report its financial […]
KULR Regains Compliance with NYSE American Stockholders’ Equity Requirement
HOUSTON, Dec. 18, 2024 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), a leader […]
Channel Therapeutics Announces Positive Efficacy Data For a Depot Formulation of a NaV1.7 Inhibitor in a Preclinical In Vivo Nerve Block Model
FREEHOLD, N.J., Dec. 18, 2024 (GLOBE NEWSWIRE) — Channel Therapeutics Corporation, (“Channel” or the “Company”), (NYSE American: CHRO), a pioneer […]
CleanCore Solutions, Inc. (ZONE) Applauds EPA’s Recent Ban of Two Cancer-Causing Chemicals
Omaha, NE, Dec. 18, 2024 (GLOBE NEWSWIRE) — CleanCore Solutions, Inc. (NYSE American: ZONE) (“CleanCore” or the “Company”), developer of […]
Quoin Pharmaceuticals Announces Positive Interim Data from Two Ongoing Netherton Syndrome Clinical Studies
Clinical Data from First Subject Dosed Twice Daily with QRX003 in Open Label Study Is Positive at Mid-point of Testing […]
